These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3085896)

  • 21. [Pathogenesis and therapy of osteoporosis in the postmenopausal period].
    Keck E; Krüskemper HL
    Gynakologe; 1986 Dec; 19(4):220-6. PubMed ID: 3817593
    [No Abstract]   [Full Text] [Related]  

  • 22. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.
    Caniggia A; Nuti R; Loré F; Vattimo A
    J Endocrinol Invest; 1984 Aug; 7(4):373-8. PubMed ID: 6094649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The calcium deficiency model for osteoporosis.
    Nordin BE; Morris HA
    Nutr Rev; 1989 Mar; 47(3):65-72. PubMed ID: 2649803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone matrix and mineral abnormalities in postmenopausal osteoporosis.
    Burnell JM; Baylink DJ; Chestnut CH; Mathews MW; Teubner EJ
    Metabolism; 1982 Nov; 31(11):1113-20. PubMed ID: 7132738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrition and osteoporosis: facts and uncertainties about calcium and vitamin D recommendations.
    Amorim Cruz JA
    Forum Nutr; 2003; 56():178-81. PubMed ID: 15806851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcitriol in the treatment of postmenopausal osteoporosis.
    Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
    Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vitamin D endocrine system, calcium metabolism, and osteoporosis.
    Slovik DM
    Spec Top Endocrinol Metab; 1983; 5():83-148. PubMed ID: 6367121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
    Need AG; Morris HA; Hartley TF; Horowitz M; Nordin BE
    Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Baylink DJ; Matthews M; Nelp WB; Sisom K; Chesnut CH
    Metabolism; 1984 Apr; 33(4):295-303. PubMed ID: 6423929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis.
    Chesnut CH; Baylink DJ; Sisom K; Nelp WB; Roos BA
    Metabolism; 1980 Jun; 29(6):559-62. PubMed ID: 7382823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium and osteoporosis.
    Avioli LV
    Annu Rev Nutr; 1984; 4():471-91. PubMed ID: 6380541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.
    Ismail F; Epstein S; Pacifici R; Droke D; Thomas SB; Avioli LV
    Calcif Tissue Int; 1986 Oct; 39(4):230-3. PubMed ID: 3098385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
    Aloia JF; Vaswani A; Meunier PJ; Edouard CM; Arlot ME; Yeh JK; Cohn SH
    Calcif Tissue Int; 1987 May; 40(5):253-9. PubMed ID: 2981045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women.
    Nordin BE; Robertson A; Seamark RF; Bridges A; Philcox JC; Need AG; Horowitz M; Morris HA; Deam S
    J Clin Endocrinol Metab; 1985 Apr; 60(4):651-7. PubMed ID: 3156144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.
    Chesnut CH; Nelp WB; Baylink DJ; Denney JD
    Metabolism; 1977 Mar; 26(3):267-77. PubMed ID: 319322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis.
    Wheeler M
    Med Clin North Am; 1976; 60(6):1213-24. PubMed ID: 790047
    [No Abstract]   [Full Text] [Related]  

  • 39. New approaches to the problems of osteoporosis.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
    Riggs BL; Nelson KI
    J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.